NCT06752863View on ClinicalTrials.gov

Labetalol Infusion and Dexmedetomidine Infusion in Hypotensive Anesthesia

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 27, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hypotensive AnesthesiaEar, Nose and Throat Procedure
Interventions
DRUG

Hypotensive anesthesia in ear, nose and throat surgeries using labetalol and dexmedetomidine infusions

The study compares the role of Labetalol infusion versus Dexmedetomidine infusion in hypotensive anesthesia in patients having ear, nose and throat surgeries

Trial Locations (1)

11517

RECRUITING

Ain Shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT06752863 - Labetalol Infusion and Dexmedetomidine Infusion in Hypotensive Anesthesia | Biotech Hunter | Biotech Hunter